Information Provided By: 
Fly News Breaks for July 20, 2017
PACB
Jul 20, 2017 | 05:56 EDT
Piper Jaffray analyst William Quirk says his channel checks found 13 Sequel systems in the quarter, down sequentially from 21 found in Q1 and 13 in Q4. Pacific Biosciences typically places two times the channel check, which would imply 26 systems in the quarter, Quirk tells investors in a research note. He lowered his 33 estimate to 30 and sees risk to Q2 numbers. The analyst keeps a Neutral rating on Pacific Biosciences and dropped his price target for the shares to $4.80 from $5.10.
News For PACB From the Last 2 Days
PACB
Apr 22, 2024 | 09:47 EDT
PACB
Apr 22, 2024 | 04:46 EDT
